A new study published in Nature reports on a new antibiotic that binds to the ribosome of bacterial cells and stops drug-resistant pathogens from making mice sick.
Fourth year UIC doctoral candidate Amanda Maldonado is among 16 leaders welcomed to the Yale Ciencia Academy for Career Development, a program to assist promising Hispanic and Latinx scientists transition into research careers.
Researchers at the University of Illinois Chicago have identified a potent new antiviral compound that can effectively block viral replication in human cells. The discovery, spearheaded by the UICentre for Drug Discovery, could…
The Chicago Office of Technology Management works with faculty, staff, and students to advance research, education, and economic development. Technology transfer is the process of moving scientific discoveries from the inventor’s mind to…
Dr. Kitajewski's work has uncovered mechanisms of embryonic, ovarian, retinal and tumor angiogenesis and contributed to our understanding of fertility, preeclampsia, vascular malformations, retinopathies, tumor angiogenesis and metastasis.
A new type of breast cancer drug developed by researchers at the University of Illinois Chicago can help halt progression of disease and is not toxic, according to phase 1 clinical trials.
When retired UIC College of Pharmacy professor Donald Waller, along with his best friend, Lourens Zaneveld, began working on their next-generation contraceptive for women, they sought to fill a simple, but widespread, need in the market.
Gov. JB Pritzker on Wednesday announced that the State of Illinois is moving forward with $500 million in capital funding for the University of Illinois System's Illinois Innovation Network (IIN) and Discovery Partners Institute (DPI).
After nearly two years of planning, the Discovery Partners Institute has cleared its final state regulatory hurdle and can launch operations in earnest, at least temporarily.
A new donation from a longtime supporter of the University of Illinois at Chicago marks a milestone for the proposed Drug Discovery and Innovation Pavilion, a $100 million, five-story, 112,000-square-foot contemporary research building.…
The University of Illinois Board of Trustees today gave its unanimous support to the Discovery Partners Institute, the new research and education enterprise led by the University of Illinois System. DPI will boost the state’s economy.
The University of Illinois at Chicago will work with TB Alliance to help find new drug treatments for tuberculosis, a bacterial infection considered to be one of the leading causes of death worldwide.…
The University of Illinois at Chicago and Deerfield Management announced today the establishment of West Loop Innovations, LLC. The company will help accelerate the commercialization of therapeutics developed at UIC. Deerfield will provide…
New research facilities to build on breakthroughs in therapeutic drugs and computer technology at the University of Illinois at Chicago are among top priorities in start-up plans for a new statewide innovation network…
Shingrix is safer to administer to patients with weaker immune systems because it uses a recombinant protein antigen instead of an attenuated live virus.
